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the jaws of the bipolar clamp toward
the coronary-free spot of the mitral an-
nulus. This can be found toward P2 in
right coronary dominance, toward P3
in codominance, and near the crux cor-
dis in left coronary dominance. These
facts are clearly shown in mitral annu-
lus dissections, where the right coro-
nary or circumflex artery circulates on
the atrial side within the fat of the atrio-
ventricular groove. Our study empha-
sizes Benussi and colleagues’ concept
of tailoring the ablation pattern to the
coronary anatomy, but we profoundly
disagree that the actual technology
used in bipolar radiofrequency can
reach the posterior mitral annulus. We
have tested thiswith the 2most referred
bipolar clamps in the literature, Cardi-
oblate (Medtronic, Minneapolis, MN)
and AtriCure (AtriCure, Inc, Cincin-
nati, OH), in 8 explanted human hearts.
Neither system reached the mitral an-
nulus in any heart. Rigor mortis or con-
tracture was not present in any heart at
the time of testing because these hearts
were studied soon after explantation
and preservation had been at 4C. I per-
sonally performed the studies in all of
the 8 explanted hearts, and there was
no rigor or rigidity that limited our
clamp positioning. The hearts felt like
they were cardioplegically arrested.
Our findings are corroborated with
the postoperative necropsy of a heart
inwhich a bipolar radiofrequency abla-
tion was performed under cardioplegic
arrest. Macroscopic and microscopic
studies confirmed that the ablation
line did not reach the mitral annulus.
The difficulty of reaching the mitral
annulus at the level of the posterior leaf-
let with a clamp can be described by 3
anatomic facts. First, there is an impor-
tant discrepancy inmuscle thickness be-
tween the atrial and the ventricular
walls. Second, the muscle of the atrial
wall is followed by the posterior mitral
leaflet in the endocardial side of the thick
ventricular wall. Third, at the epicardial
level, fat covers the difference in thick-
ness between both walls at the atrioven-
tricular groove, mainly covering the
atrial wall and hosting the coronary ar-
tery and sinus. Clamping the atrial tissue
including the annulus would entail
clamping the firstmillimeters of theven-
tricular wall, the last one being 9 to 11
mm thick and impossible to clamp
with actual bipolar technology. This is
why even in small left atria, and regard-
less of the length of the radiofrequency
clamp, it is impossible to reach themitral
annulus at the posterior leaflet.
The results obtained by Benussi and
colleagues3 using only bipolar radiofre-
quency technology are encouraging,
but we doubt all patients in their report
have the mitral line complete. There-
fore, it is possible that this line is not
as important as previously thought or
that leaving a 4- to 8-mm gap in the
line does not influence the results.
Manuel Castella´, MD, PhD
Cardiovascular Surgery
Hospital Clinic
University of Barcelona
Barcelona, Spain
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Letters to the Editor
The JournalCHANGES IN NONINFARCTED
MYOCARDIUM EXPLAIN
BENEFITS OF ON-PUMP
BEATING-HEART CORONARY
ARTERY BYPASS GRAFTING
FOR ACUTE MYOCARDIAL
INFARCTION
To the Editor:
We read with great interest the article
by Miyahara and associates1 comparing
outcomes in patients undergoing emer-
gency coronary artery bypass grafting
(CABG) for acute myocardial infarction
(MI), using on-pump beating-heartof Thoracic and Cardiovascular Surge(OPBH) surgery, with outcomes of con-
ventional CABG using aortic cross-
clamping and cardioplegia. This study
is one of four published over the past 3
years reporting improved outcomes
with this new technique.
These studies claim the avoidance
of reperfusion injury after crossclamp-
ing of the aorta as the reason for the ben-
efits seen. However, we believe an
important concept has been overlooked
here, namely, the effects of global ische-
mia on the noninfarcted myocardium.
There is extensive evidence, especially
from the work of Gudbjarnason and as-
sociates,2 that the ‘‘normal,’’ nonin-
farcted myocardium, remote from the
infarct, undergoes profound physiologic
and biochemical changes as a result of
the infarct. The noninfarcted myocar-
dium is far from normal owing to deple-
tion of adenosine triphosphate and
creatine phosphate, increased oxygen
consumption, and a reduction in glyco-
gen levels2,3 (Figure 1). These changes
indicate a state of stimulatedmetabolism
in response to the increased workload
performed by the noninfarcted myocar-
dium to compensate for the nonfunc-
tioning, akinetic infarct. As a result,
hypertrophy occurs in the noninfarcted
portion in an attempt to maintain normal
cardiac function.4 These metabolic and
structural changes render the nonin-
farcted myocardium highly susceptible
to the effects of ischemia, such as those
induced by crossclamping the aorta.3
Many years ago, in our laboratory,
we studied the effects of cardioplegic
arrest on the recently infarcted heart
in greyhound dogs.3 After cardioplegic
arrest, we demonstrated a dramatic
decrease in recovery of function in
the recently infarcted hearts compared
with recovery in noninfarcted hearts
(18% recovery of prearrest function in
infarcted hearts compared with 56%
in noninfarcted hearts; P< .001). The
implication from this work is that the
avoidance of global ischemia is the
major reason for the success of
OPBH surgery after MI.
We have developed a novel tech-
nique of myocardial preconditioningry c Volume 137, Number 6 1575
We are impressed by the fact that
the metabolic2 and structural3 changes
in the myocardium after infarction
were investigated many years ago dur-
ing the early stages of cardiac surgery.
We have treated another 45 patients
with AMI since our report and have ap-
plied this technique consistently. The
results have been excellent, with an
overall hospital mortality of 2.2%.
The only patient who died had a left
main trunk infarction and required per-
cutaneous cardiopulmonary support
preoperatively. We confirmed the reli-
ability of this technique. Technological
advances in devices such as a suction
stabilizer, apical suction cardiac posi-
Letters to the EditorFIGURE 1. Myocardium after coronary artery occlusion. The infarcted myocardium is necrotic and
akinetic. The larger noninfarcted myocardium undergoes physiologic and biochemical changes.
ATP, Adenosine triphosphate; CP, creatine phosphate; MVO2, myocardial oxygen consumption.Reply to the Editor:
We appreciate the comments of
Varatharajah and Rosenfeldt on our
article, ‘‘On-Pump Beating-Heart
Coronary Artery Bypass Grafting After
AcuteMyocardial InfarctionHas Lower
Mortality and Morbidity.’’1 The com-
ments indicate the importance of pre-
serving the function of noninfarcted
myocardium, which is highly suscep-
tible to the effects of ischemia, and
represent theoretical grounds for the
benefits of avoiding reperfusion injury
after crossclamping the aorta during cor-
onary artery bypass grafting (CABG) in
acute myocardial infarction (AMI).
tioning device, intravascular shunt,
and temporary occlusion device enable
us to perform on-pump beating-heart
surgery reliably and safely.
To save these critically ill patients,
in addition to avoiding cardioplegic ar-
rest, we would like to emphasize the
need for cardiopulmonary bypass to
compensate the residual myocardial
function and visceral organ failure.
We know little about orotic acid. On
the basis of experimental findings in
dogs,4 it is attractive and may help to
improve the results. In our series of pa-
tients with AMI, the mean time inter-
val from the onset of AMI to CABG
was 18 hours. Therefore, orotic acid
can be administered only during the
few hours that are available between
admission and surgery, allowing one
or two doses at most. Further study is
required to determine whether preop-
erative metabolic therapy with oral or-
otic acid is effective in this clinical
setting.
In summary, on-pump beating-heart
CABG is the best form of surgical
treatment for patients with AMI.
Ken Miyahara, MD
Akio Matsuura, MD
Haruki Takemura, MD
Shunei Saito, MD
Aichi Cardiovascular and
Respiratory Center
Division of Cardiovascular Surgery
Ichinomiya, Aichi, Japanby 2 to 4 days of preoperative meta-
bolic therapy with oral orotic acid as
a means of protecting the recently in-
farcted heart during emergency cardiac
surgery. Orotic acid is a pyrimidine
precursor that can augment the rate of
synthesis of RNA, proteins, and glyco-
gen. Pretreatment with orotic acid, in
animal models, improves the func-
tional recovery of the infarcted heart
after cardioplegic arrest (43% recovery
of prearrest function in orotic acid–treated
groups compared with 18% in untreated
groups; P< .001).3
In conclusion, the results of Miya-
hara and associates are promising and
provide practical evidence for the ben-
efits of avoiding crossclamping of the
aorta. These benefits can best be ex-
plained by an improved understanding
of the changes that occur in the remote,
noninfarcted myocardium. We have
shown that these changes can be atten-
uated by preoperative metabolic ther-
apy with orotic acid. We propose that
the use of the OPBH technique, com-
bined with metabolic strategies, could
result in better recovery in patients un-
dergoing cardiac surgery after MI than
with either technique alone and could
allow cardiac surgery after recent MI
to be performed even more safely and
effectively.
Kapilan Varatharajah
Franklin L. Rosenfeldt, MD, FRACS
The Alfred CJOB Cardiothoracic1576 The Journal of Thoracic anSurgery
Prahran, Victoria, Australia
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